Exane Derivatives’s Magnite MGNI Stock Holding History

Exane Derivatives’s Portfolio MGNI Stock Details MGNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,928	Closed	-$82K	–	930
2021 Q3	$82K	Buy	2,928 +1,085	+59%	+$32.7K	0.02%	555
2021 Q2	$57.2K	Buy	+1,843	New	+$62.4K	0.01%	636

Other funds holding MGNI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Edenbrook Capital Mt. Kisco, New York $321M AUM 79.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's MGNI Position: Q4 2021 in Review

Exane Derivatives sold out of Magnite (MGNI) in Q4 2021, closing a stake of 2,928 shares — an estimated $82K sold.

Exane Derivatives first reported a position in MGNI in Q2 2021 and held it in 2 quarters. The position peaked at $82K in Q3 2021. 247 funds tracked by Wall St. Rank hold MGNI as of Q4 2021.

Exane Derivatives reported no remaining Magnite position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 2,928 Magnite shares in Q4 2021, an estimated $82K.
Exane Derivatives first reported a position in Magnite in Q2 2021 and held it in 2 quarters.
Exane Derivatives's Magnite position peaked at $82K in Q3 2021.
247 funds tracked by Wall St. Rank held Magnite as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.